TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$2.10
-0.09 (-4.11%)
Open$2.19
Previous Close$2.19
Day High$2.19
Day Low$2.04
52W High$2.95
52W Low$0.99
Volume—
Avg Volume16.3K
Market Cap25.23M
P/E Ratio—
EPS$-0.02
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+465.7% upside
Current
$2.10
$2.10
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.01M | 8.58M | 4.86M |
| Net Income | -566,858 | -1,453,896 | 1.27M |
| Profit Margin | -18.8% | -17.9% | 26.2% |
| EBITDA | -3,989,899 | -10,801,949 | 2.17M |
| Free Cash Flow | — | — | 1.08M |
| Rev Growth | -64.9% | -64.9% | +8.5% |
| Debt/Equity | — | — | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |